Stock QRON QRONS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Qrons Inc.

Equities

QRON

US74737F1012

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 12:55:39 2024-03-08 EST 		5-day change 1st Jan Change
0.1855 USD -11.68% Intraday chart for Qrons Inc. -.--% -19.35%
04-15 Qrons Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Qrons Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 29.55 6.278 5.183 10.63 6.854 3.139
Enterprise Value (EV) 1 29.44 6.577 5.63 11.2 7.604 4.015
P/E ratio -7.47 x -4.03 x -7.74 x -9.96 x -9.25 x -3.94 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF 29.8 x 72.8 x 78.3 x 27.1 x 143 x 43.5 x
FCF Yield 3.36% 1.37% 1.28% 3.69% 0.7% 2.3%
Price to Book 276 x -12.4 x -7.46 x -9.64 x -5.36 x -2.11 x
Nbr of stocks (in thousands) 12,850 13,080 13,290 13,290 13,440 13,650
Reference price 2 2.300 0.4800 0.3900 0.8000 0.5100 0.2300
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-11 23-03-31 24-04-15
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA - - - - - -
EBIT 1 -3.905 -1.516 -0.5537 -0.802 -0.6296 -0.6437
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -3.931 -1.547 -0.663 -1.068 -0.7335 -0.7893
Net income 1 -3.931 -1.547 -0.663 -1.068 -0.7335 -0.7893
Net margin - - - - - -
EPS 2 -0.3078 -0.1190 -0.0504 -0.0804 -0.0552 -0.0583
Free Cash Flow 1 0.9888 0.0903 0.0719 0.4136 0.0531 0.0923
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-11 23-03-31 24-04-15
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.3 0.45 0.57 0.75 0.88
Net Cash position 1 0.12 - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.99 0.09 0.07 0.41 0.05 0.09
ROE (net income / shareholders' equity) -6,164% 772% 110% 119% 61.6% 57%
ROA (Net income/ Total Assets) -1,812% -594% -383% -1,081% -2,064% -23,068%
Assets 1 0.217 0.2604 0.1733 0.0988 0.0355 0.003422
Book Value Per Share 2 0.0100 -0.0400 -0.0500 -0.0800 -0.1000 -0.1100
Cash Flow per Share 2 0.0100 0.0100 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-11 23-03-31 24-04-15
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QRONS INC. Stock Qrons Inc.
-19.35% 2.53M
MODERNA, INC. Stock Moderna, Inc.
+18.62% 47.02B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.25% 41.76B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 28.8B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.34% 26.05B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.25% 19.15B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.64% 12.55B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.78% 12.34B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.54% 11.82B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QRON Stock
  4. Financials Qrons Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW